Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transfer of Genetically Engineered Lymphocytes in Melanoma Patients: A Phase 1 Dose Escalation Study

NCT01586403 is registered in ClinicalTrials.gov with Loyola University as lead sponsor.

NCT NCT01586403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01586403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transfer of Genetically Engineered Lymphocytes in Melanoma Patients: A Phase 1 Dose Escalation Study
Lead sponsor
Loyola University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 31, 2012
Completion date
September 30, 2028
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma